European award for medicinal chemists: New active ingredients for the treatment of infections

Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.

Background Research:

Martin Empting is a distinguished researcher who has dedicated his career to the development of new active ingredients that can counter bacterial and viral infections. He currently works in academia, striding forward with ambitious research projects carried out with great diligence.

In Europe, he became a runner-up for the „Young Medicinal Chemist in Academia Prize“. This esteemed award is offered by the European Federation of Medicinal Chemistry (EFMC) to young chemists pursuing groundbreaking work in their academic research. The EFMC serves as an umbrella organization for numerous European societies specializing in medicinal chemistry and brings together experienced professionals from academia, industry, and regulatory authorities.

FAQs:

1. Who is Martin Empting?
Martin Empting is an ambitious researcher working on the development of new substances that can be used to treat various bacterial and viral infections.

2. What recognition has he received recently?
He has been awarded as a runner-up for the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC).

3. What type of work does this prize recognize?
The prize recognizes remarkable research efforts undertaken by young chemists involved in academic studies with potential societal impact.

4. What does Mr Empting’s achievement mean?
His recent attainment signifies professional recognition trialed at high standards held by EFMC – it highlights his significant contributions towards finding innovative solutions to treat infectious diseases.

5.What are these active substances he’s developing doing?
These active substances are aimed at combating harmful bacteria and viruses which cause health problems – potentially they could pave way for advanced medicines effective against diverse set of diseases.

6.What’s unique about this award?
This award imparts recognition specifically within Europe’s scientific community engaged in medicinal chemistry, favoring outstanding individuals constantly striving toward uprooting healthcare issues via innovative methods.

7.Who offers this Young Medicinal Chemist in Academia Prize?
The European Federation of Medicinal Chemistry (EFMC) confers this award.

8.What does the EFMC do?
The EFMC is an organization made up of multiple European societies that specialize in medicinal chemistry. This collective body includes professionals from academia, industry, and regulatory authorities working together towards better health-based solutions.

Originamitteilung:

Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.

share this recipe:
Facebook
Twitter
Pinterest

Weitere spannende Artikel

Keeping Bugs Healthy

There is fresh momentum in our protein supply — and it’s moving along on six legs. Insects are a source of protein with a smaller resource footprint than conventional alternatives in every possible way. To ensure the safety of insect farms and their products, Fraunhofer researchers have developed a system that reliably detects pathogens right away, at low cost and with the possibility of automation.

Read More

Gesichert gesundes Krabbeln

Es ist Bewegung gekommen in unsere Eiweißversorgung – Bewegung auf sechs Beinen: Insekten sind eine Proteinquelle, die zu erschließen in jeder Hinsicht ressourcenschonender ist als herkömmliche Alternativen. Um die Sicherheit der Insektenzucht und ihrer Produkte zu gewährleisten, haben Fraunhofer-Forschende ein System entwickelt, das Krankheitserreger zuverlässig detektiert – umgehend, kostengünstig und automatisierbar.

Read More